Time-to-first exacerbation, adherence, and medical costs among US patients receiving umeclidinium/vilanterol or tiotropium as initial maintenance therapy for chronic obstructive pulmonary disease: a retrospective cohort study

BACKGROUND: Adherence to chronic obstructive pulmonary disease (COPD) maintenance medication is important for managing symptoms and exacerbation risk, and is associated with reduced mortality, hospitalizations, and costs. This study compared on-treatment exacerbations, medical costs, and medication...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMC Pulm Med
Päätekijät: Slade, David, Ray, Riju, Moretz, Chad, Germain, Guillaume, Laliberté, François, Shen, Qin, Duh, Mei Sheng, Mahendran, Malena, Hahn, Beth
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2021
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8325860/
https://ncbi.nlm.nih.gov/pubmed/34332555
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12890-021-01612-5
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia